SR One News

BY CATEGORY: ALL / NOTABLE / CLINICAL IMPACT / NEW INVESTMENTS / FINANCING AND PARTNERSHIPS / PEOPLE

BY YEAR: 2023 / 2022 / 2021 / 2020

Nimbus Therapeutics secures $210M in private financing

Frances Benson 9/6/23 Frances Benson 9/6/23

Nimbus Therapeutics secures $210M in private financing

Read More

FORE Biotherapeutics announces $75M in Series D and CEO Transition

Frances Benson 8/23/23 Frances Benson 8/23/23

FORE Biotherapeutics announces $75M in Series D and CEO Transition

Read More

ADARx Pharmaceuticals announces oversubscribed $200M Series C

Frances Benson 8/9/23 Frances Benson 8/9/23

ADARx Pharmaceuticals announces oversubscribed $200M Series C

Read More

Simcha Therapeutics announces clinical trial collaboration with Merck to evaluate ST-067 in combination with KEYTRUDA® (Pembrolizumab)

Frances Benson 4/5/23 Frances Benson 4/5/23

Simcha Therapeutics announces clinical trial collaboration with Merck to evaluate ST-067 in combination with KEYTRUDA® (Pembrolizumab)

Read More

ADARx Pharmaceuticals raises $46M in Series B-1 and appoints Dr. Lorence Kim to Board of Directors

Frances Benson 1/20/23 Frances Benson 1/20/23

ADARx Pharmaceuticals raises $46M in Series B-1 and appoints Dr. Lorence Kim to Board of Directors

Read More

Akamis Bio raises $30M financing and relaunches with name change from PsiOxus Therapeutics

Frances Benson 1/5/23 Frances Benson 1/5/23

Akamis Bio raises $30M financing and relaunches with name change from PsiOxus Therapeutics

Read More

HotSpot Therapeutics launches strategic collaboration with AbbVie to further expand immunology pipeline

Frances Benson 12/6/22 Frances Benson 12/6/22

HotSpot Therapeutics launches strategic collaboration with AbbVie to further expand immunology pipeline

Read More

ARS Pharmaceuticals closes merger with Silverback Therapeutics and currently has over $280M in cash

Frances Benson 11/8/22 Frances Benson 11/8/22

ARS Pharmaceuticals closes merger with Silverback Therapeutics and currently has over $280M in cash

Read More

Odyssey Therapeutics raises $168M in Series B

Frances Benson 10/13/22 Frances Benson 10/13/22

Odyssey Therapeutics raises $168M in Series B

Read More

Nimbus Therapeutics announces research collaboration and license agreement with Lilly

Frances Benson 10/11/22 Frances Benson 10/11/22

Nimbus Therapeutics announces research collaboration and license agreement with Lilly

Read More

Nimbus Therapeutics closes $125M in private financing

Frances Benson 9/12/22 Frances Benson 9/12/22

Nimbus Therapeutics closes $125M in private financing

Read More

ARS Pharmaceuticals and Silverback Therapeutics announces merger

Frances Benson 7/21/22 Frances Benson 7/21/22

ARS Pharmaceuticals and Silverback Therapeutics announces merger

Read More

MiroBio raises $97M in Series B

Frances Benson 6/29/22 Frances Benson 6/29/22

MiroBio raises $97M in Series B

Read More

Arcellx raises $128M in follow-on financing

Frances Benson 6/21/22 Frances Benson 6/21/22

Arcellx raises $128M in follow-on financing

Read More

Dren Bio raises $65M in Series B

Frances Benson 6/14/22 Frances Benson 6/14/22

Dren Bio raises $65M in Series B

Read More

Nkarta Therapeutics raises $230M in follow-on financing

Frances Benson 4/28/22 Frances Benson 4/28/22

Nkarta Therapeutics raises $230M in follow-on financing

Read More

Dren Bio announces research collaboration and license agreement with Pfizer

Frances Benson 1/11/22 Frances Benson 1/11/22

Dren Bio announces research collaboration and license agreement with Pfizer

Read More

HotSpot Therapeutics and Caris Life Sciences announce collaboration

Frances Benson 1/10/22 Frances Benson 1/10/22

HotSpot Therapeutics and Caris Life Sciences announce collaboration

Read More

Odyssey Therapeutics acquires Rahko

Frances Benson 1/6/22 Frances Benson 1/6/22

Odyssey Therapeutics acquires Rahko

Read More

HotSpot Therapeutics raises $100M in Series C

Frances Benson 11/29/21 Frances Benson 11/29/21

HotSpot Therapeutics raises $100M in Series C

Read More